Albert Bourla, CEO of Pfizer, joins 'Money Movers' to discuss drug pricing, the impact on artificial intelligence on ...

Big pharma is grappling with new drug pricing deals and roughly $300 billion in potential lost revenue from patent ...

U.S. pharmaceutical companies are stepping up their campaign for higher drug prices in Europe, in some cases threatening to ...

US pharma giants seek to dodge Trump’s campaign to lower drug costs . American pharmaceutical corporations are reportedly ...

Speaking before a darkened ballroom, US Chamber of Commerce CEO Suzanne Clark called on executives to be “fearless” in defence of free markets over government control and ...

Pharmaceutical companies seek to make up lost revenue after striking deals with Donald Trump to lower costs in US ...

Speaking in front of a darkened ballroom on Thursday, U.S. Chamber of Commerce CEO Suzanne Clark called on executives to be ...

David Ricks, CEO of the Indiana drugmaker, has cut deals with the president to slash prices and build American. Trump has showered him with praise.

Business leaders are urged to defend free markets against government control. Many top executives are hesitant to openly ...

A day earlier, Albert Bourla, CEO of Pfizer, said he was annoyed by Health Secretary Robert F Kennedy Jr's move to roll back ...